Back to top

20 Day Moving Average Support appears for CHRS after 7.93% move

Coherus BioSciences, Inc. (CHRS) — SwingTradeBot Technical Analysis Report · Jul 6, 2026, 17:45 ET
CHRS posted a 7.93% gain on Monday, July 6th, accompanied by 0.3× normal trading volume. Mixed technical signals appeared with 20 DMA Support suggesting upside potential, while 50 DMA Resistance indicated possible weakness — creating a conflicted technical picture. Key support levels exist at 1.46, 1.36 & 1.29, with resistance at 1.64, 1.71 & 1.81.

Current SwingTradeBot Technical Rating of CHRS: D

Is this the only signal? Not even close. Explore the full breakdown at SwingTradeBot.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Coherus Oncology, Inc. (CHRS)